[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-336299-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-336299-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","immunological-aspects-of-cancer-cell-metabolism-review","Immunological Aspects of Cancer Cell Metabolism - review","","Cancer cells adeptly manipulate their metabolic processes to evade immune detection, increasing the complexity of cancer progression and therapy. This review examines how cancer cell metabolism shapes the immune-editing landscape, focusing on metabolic reprogramming that enables tumor survival despite immune surveillance. It analyzes tumor microenvironment interactions, where enhanced glucose and amino-acid metabolism coexists with immunosuppressive states that blunt immune function. Emerging immunotherapy effectiveness is linked to metabolic competition between tumor and immune cells, highlighting targets such as the Warburg effect and glutamine addiction.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/immunological-aspects-of-cancer-cell-metabolism-review/336299/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/immunological-aspects-of-cancer-cell-metabolism-review/336299.png","ImageObject",300,407,{"name":42,"@type":43},"Ivy","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-14","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What does the review emphasize about cancer cell metabolism and immune evasion?","Question",{"text":63,"@type":64},"It highlights that cancer cells reprogram metabolism to evade immune detection by creating an immunosuppressive tumor microenvironment and fostering immune escape.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does immune-editing influence cancer progression according to the article?",{"text":68,"@type":64},"The article describes immune-editing as selection pressure from immune cells that drives tumors toward genetic/epigenetic changes and variants with reduced immunogenicity or immune-evading properties.",{"name":70,"@type":61,"acceptedAnswer":71},"Which metabolic pathways are discussed as potential therapeutic targets?",{"text":72,"@type":64},"The review points to pathways such as the Warburg effect and glutamine addiction, arguing that disrupting these processes could improve responses to immunotherapy.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},336299,1790187259,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},549758252649,"https://ap-avatar.wpscdn.com/avatar/8000253669c5317157?_k=1778319167496531819","Review  \nImmunological Aspects of Cancer Cell Metabolism  \nSisca Ucche 1,2 and Yoshihiro Hayakawa 1, *  \nCitation: Ucche, S.; Hayakawa, Y. Immunological Aspects of Cancer Cell Metabolism. Int. J. Mol. Sci. 2024, 25, 5288. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)ijms25105288  \nAcademic Editor: Efstratios Stratikos  \nReceived: 12 April 2024  \nRevised: 9 May 2024  \nAccepted: 9 May 2024  \nPublished: 13 May 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Institute of Natural Medicine, University of Toyama, Toyama 930-0194, Japan; [sisca.ucche@mail.ugm.ac.id](sisca.ucche@mail.ugm.ac.id)  \n2 Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia  \n* [Correspondence: haya@inm.u-toyama.ac.jp](Correspondence: haya@inm.u-toyama.ac.jp); Tel.: +81-76-434-7620  \nAbstract: Cancer cells adeptly manipulate their metabolic processes to evade immune detection, a phenomenon intensifying the complexity of cancer progression and therapy. This review delves into the critical role of cancer cell metabolism in the immune-editing landscape, highlighting how metabolic reprogramming facilitates tumor cells to thrive despite immune surveillance pressures. We explore the dynamic interactions within the tumor microenvironment (TME), where cancer cells not only accelerate their glucose and amino acid metabolism but also induce an immunosuppressivestate that hampers effective immune response. Recent ﬁndings underscore the metabolic competition between tumor and immune cells, particularly focusing on how this interaction inﬂuences the efﬁcacy of emerging immunotherapies. By integrating cutting-edge research on the metabolic pathways of cancer cells, such as the Warburg effect and glutamine addiction, we shed light on potential therapeutic targets. The review proposes that disrupting these metabolic pathways could enhance the response to immunotherapy, offering a dual-pronged strategy to combat tumor growth and immune evasion.  \nKeywords: cancer; progression; metabolism; immune surveillance; immune escape  \n1. Background  \nNormal healthy cells can evolve into transformed cancer cells through various mechanisms, including genetic mutations that lead to uncontrolled cell growth, epigenetic alterations that change gene expression without altering the DNA sequence, and disruptions in cellular signaling pathways that govern cell proliferation and death [1] . During such cancer development, it is known that immune cells are essential for controlling the development and progression of cancer cells. This process has been regarded as a cancer immune surveillance process where immune cells work cooperatively to eliminate cancer cells to protect the host. However, an extensive series of previous works revealed that the host immune system works not only for protection but also for scalping or editing cancer cells to escape the immune surveillance process, thereby being revised as a cancer immune-editing process. Through the cancer immune-editing process, cancer cells proceed to genetic and epigenetic changes that form a new tumor variant under the potent selection pressure from immune cells. Alternatively, immune cells from a heterogeneous cancer population can select cancer cells with poorer immunogenicity and/or immune-evading properties. Those immune-escaped cancer cell variants can proceed with the disease progression to proliferate and metastasize [2] .  \nConsidering the plasticity nature of cancer cells, several mechanisms of cancer cells for immune escape have been noted, such as decreasing their immunogenicity and/or inducing an immunosuppressive environment [3] . The tumor microenvironment ","cbCaiahGH9VOTpZ3","https://ap.wps.com/l/cbCaiahGH9VOTpZ3","pdf",768499,14,"English","# Background\n## Cancer immune surveillance and immune editing\n## Tumor microenvironment and immunosuppressive states\n# Immunological Components of Tumor Microenvironment\n## Immune cell types and their roles","[{\"question\":\"What does the review emphasize about cancer cell metabolism and immune evasion?\",\"answer\":\"It highlights that cancer cells reprogram metabolism to evade immune detection by creating an immunosuppressive tumor microenvironment and fostering immune escape.\"},{\"question\":\"How does immune-editing influence cancer progression according to the article?\",\"answer\":\"The article describes immune-editing as selection pressure from immune cells that drives tumors toward genetic/epigenetic changes and variants with reduced immunogenicity or immune-evading properties.\"},{\"question\":\"Which metabolic pathways are discussed as potential therapeutic targets?\",\"answer\":\"The review points to pathways such as the Warburg effect and glutamine addiction, arguing that disrupting these processes could improve responses to immunotherapy.\"}]","Immunological Aspects of Cancer Cell Metabolism - review | PDF",1790014465,35,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5637dfacb4efbf6ddc5c87da97e9e0c2.webp",983,1390,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/776187093df56a4d3449ce4ed624794d.webp",982,1388,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dec3b31774a34f44a455c54d7ea1733e.webp",981,1387,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d0afdd914dc16488ac41fcdb5823263a.webp",980,1385]